NCT Number: NCT00090272
A Single Dose of a Marketed Drug Being Studied for a New Indication to Treat Surgical Site Infection Following Colorectal Surgery as Compared to a Marketed Drug Approved for This Indication (0826-039)
The objective of this study is to evaluate the safety and efficacy of a one time dose of an intravenous marketed drug being evaluated for a new indication as compared to a marketed drug already approved for the prevention of surgical site infection following colorectal surgery.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
About this study
The duration of treatment is 1 day.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Male or female patients 18 years of age scheduled to undergo elective colon or colorectal surgery by laparotomy must meet the following criteria:
- Surgery must be scheduled in advance.
- There must be adequate time to complete preoperative bowel preparation
Treatment and study plan
Comparator: cefotetan
DrugPrimary outcomes
-
Surgical site infection following elective colorectal surgery based on surgical site assessment.
Secondary outcomes
-
Microbiology of surgical site infection in pts who fail prevention or have distant site infection; Safety profile based on AE monitoring and lab results.
Sponsors and collaborators
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Registry information
Official study title
A Prospective, Multicenter, Double-Blind, Randomized, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of a Single Dose of Ertapenem Sodium (MK0826) Versus Cefotetan for the Prophylaxis of Surgical Site Infection Following Elective Colorectal Surgery
Important dates
- Study start
- 2002
- Primary completion
- 2005
- Study completion
- 2005
- First posted
- Aug 27, 2004
- Registry last updated
- Feb 17, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Safety and Performance of the CG-100 in Patients Undergoing Colorectal Surgery.
NCT03423485
Colorectal Surgery
Paris, Clichy, France
View Trial DetailsA Safety and Effectiveness Prospective Blinded Clinical Study to Validate xBar System as Monitoring Tool for Anastomotic Leaks Detection
NCT06168669
Anastomotic Leak, Colorectal Surgery
Orlando, Florida, United States
View Trial DetailsLaparoscopic Colorectal Surgery Using Low-pressure Combined With Warm and Humidified Carbon Dioxide Insufflation
NCT05934981
Benign or Malignant Rectal or Colon Tumors, Colonic Diseases
Bordeaux, France
View Trial DetailsEarly vs Standard Ileostomy Reversal
NCT07601594
Colorectal Surgery, Ileostomy
Lahore, Punjab Province, Pakistan
View Trial Details